Andrew Mok
Stock Analyst at Barclays
(3.29)
# 1,015
Out of 5,123 analysts
262
Total ratings
52.22%
Success rate
0.7%
Average return
Main Sectors:
Stocks Rated by Andrew Mok
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DVA DaVita | Maintains: Buy | $186 → $190 | $149.19 | +27.35% | 15 | Feb 4, 2026 | |
| BKD Brookdale Senior Living | Maintains: Overweight | $15 → $18 | $15.48 | +16.28% | 3 | Feb 3, 2026 | |
| UNH UnitedHealth Group | Maintains: Overweight | $391 → $327 | $268.42 | +21.82% | 15 | Jan 30, 2026 | |
| ELV Elevance Health | Maintains: Overweight | $404 → $393 | $333.10 | +17.98% | 16 | Jan 30, 2026 | |
| HCA HCA Healthcare | Maintains: Buy | $525 → $598 | $510.22 | +17.21% | 17 | Jan 28, 2026 | |
| UHS Universal Health Services | Maintains: Overweight | $263 → $262 | $213.29 | +22.84% | 26 | Jan 22, 2026 | |
| AVAH Aveanna Healthcare Holdings | Maintains: Overweight | $9 → $11 | $7.86 | +40.04% | 3 | Jan 16, 2026 | |
| MOH Molina Healthcare | Maintains: Underweight | $144 → $164 | $178.50 | -8.12% | 11 | Jan 5, 2026 | |
| HUM Humana | Maintains: Equal-Weight | $234 → $245 | $191.21 | +28.13% | 15 | Jan 5, 2026 | |
| CI The Cigna Group | Maintains: Overweight | $300 → $305 | $280.15 | +8.87% | 10 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $13 → $18 | $12.76 | +41.07% | 4 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $44 → $54 | $40.34 | +33.86% | 13 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 → $93 | $76.00 | +22.37% | 12 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $14 | $13.42 | +4.32% | 19 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $36 → $26 | $21.97 | +18.34% | 2 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $229 → $240 | $194.07 | +23.67% | 16 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $24 → $18 | $13.65 | +31.87% | 5 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $79 → $86 | $66.94 | +28.47% | 9 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $22 → $23 | $21.78 | +5.63% | 10 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $1.5 → $1 | $0.66 | +52.44% | 5 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $111 → $117 | $106.48 | +9.88% | 4 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $13 → $18 | $21.39 | -15.85% | 6 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $141 → $150 | $98.79 | +51.84% | 18 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $4 → $3.5 | $3.04 | +15.13% | 7 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $12 | $11.10 | +8.11% | 1 | Dec 8, 2022 |
DaVita
Feb 4, 2026
Maintains: Buy
Price Target: $186 → $190
Current: $149.19
Upside: +27.35%
Brookdale Senior Living
Feb 3, 2026
Maintains: Overweight
Price Target: $15 → $18
Current: $15.48
Upside: +16.28%
UnitedHealth Group
Jan 30, 2026
Maintains: Overweight
Price Target: $391 → $327
Current: $268.42
Upside: +21.82%
Elevance Health
Jan 30, 2026
Maintains: Overweight
Price Target: $404 → $393
Current: $333.10
Upside: +17.98%
HCA Healthcare
Jan 28, 2026
Maintains: Buy
Price Target: $525 → $598
Current: $510.22
Upside: +17.21%
Universal Health Services
Jan 22, 2026
Maintains: Overweight
Price Target: $263 → $262
Current: $213.29
Upside: +22.84%
Aveanna Healthcare Holdings
Jan 16, 2026
Maintains: Overweight
Price Target: $9 → $11
Current: $7.86
Upside: +40.04%
Molina Healthcare
Jan 5, 2026
Maintains: Underweight
Price Target: $144 → $164
Current: $178.50
Upside: -8.12%
Humana
Jan 5, 2026
Maintains: Equal-Weight
Price Target: $234 → $245
Current: $191.21
Upside: +28.13%
The Cigna Group
Jan 5, 2026
Maintains: Overweight
Price Target: $300 → $305
Current: $280.15
Upside: +8.87%
Jan 5, 2026
Upgrades: Equal-Weight
Price Target: $13 → $18
Current: $12.76
Upside: +41.07%
Jan 5, 2026
Upgrades: Overweight
Price Target: $44 → $54
Current: $40.34
Upside: +33.86%
Dec 10, 2025
Maintains: Overweight
Price Target: $87 → $93
Current: $76.00
Upside: +22.37%
Dec 4, 2025
Maintains: Equal-Weight
Price Target: $17 → $14
Current: $13.42
Upside: +4.32%
Nov 24, 2025
Maintains: Equal-Weight
Price Target: $36 → $26
Current: $21.97
Upside: +18.34%
Nov 21, 2025
Maintains: Overweight
Price Target: $229 → $240
Current: $194.07
Upside: +23.67%
Nov 21, 2025
Maintains: Equal-Weight
Price Target: $24 → $18
Current: $13.65
Upside: +31.87%
Nov 13, 2025
Maintains: Overweight
Price Target: $79 → $86
Current: $66.94
Upside: +28.47%
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $22 → $23
Current: $21.78
Upside: +5.63%
Nov 6, 2025
Maintains: Underweight
Price Target: $1.5 → $1
Current: $0.66
Upside: +52.44%
Nov 4, 2025
Maintains: Underweight
Price Target: $111 → $117
Current: $106.48
Upside: +9.88%
Nov 3, 2025
Maintains: Equal-Weight
Price Target: $13 → $18
Current: $21.39
Upside: -15.85%
Oct 30, 2025
Maintains: Overweight
Price Target: $141 → $150
Current: $98.79
Upside: +51.84%
Jul 24, 2025
Maintains: Equal-Weight
Price Target: $4 → $3.5
Current: $3.04
Upside: +15.13%
Dec 8, 2022
Initiates: Sell
Price Target: $12
Current: $11.10
Upside: +8.11%